391 related articles for article (PubMed ID: 23966881)
1. Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
Schlereth K; Heyl C; Krampitz AM; Mernberger M; Finkernagel F; Scharfe M; Jarek M; Leich E; Rosenwald A; Stiewe T
PLoS Genet; 2013; 9(8):e1003726. PubMed ID: 23966881
[TBL] [Abstract][Full Text] [Related]
2. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
3. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ
Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528
[TBL] [Abstract][Full Text] [Related]
4. DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
Schlereth K; Beinoraviciute-Kellner R; Zeitlinger MK; Bretz AC; Sauer M; Charles JP; Vogiatzi F; Leich E; Samans B; Eilers M; Kisker C; Rosenwald A; Stiewe T
Mol Cell; 2010 May; 38(3):356-68. PubMed ID: 20471942
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulation: p53-p21-RB signaling.
Engeland K
Cell Death Differ; 2022 May; 29(5):946-960. PubMed ID: 35361964
[TBL] [Abstract][Full Text] [Related]
6. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
[TBL] [Abstract][Full Text] [Related]
7. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
8. Dual regulatory roles of human AP-endonuclease (APE1/Ref-1) in CDKN1A/p21 expression.
Sengupta S; Mitra S; Bhakat KK
PLoS One; 2013; 8(7):e68467. PubMed ID: 23874636
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional induction of protein kinase C delta by p53 tumor suppressor in the apoptotic response to DNA damage.
Dashzeveg N; Yogosawa S; Yoshida K
Cancer Lett; 2016 Apr; 374(1):167-174. PubMed ID: 26884258
[TBL] [Abstract][Full Text] [Related]
10. p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo.
Timofeev O; Schlereth K; Wanzel M; Braun A; Nieswandt B; Pagenstecher A; Rosenwald A; Elsässer HP; Stiewe T
Cell Rep; 2013 May; 3(5):1512-25. PubMed ID: 23665223
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A).
Mlynarczyk C; Fåhraeus R
Nat Commun; 2014 Oct; 5():5067. PubMed ID: 25295585
[TBL] [Abstract][Full Text] [Related]
12. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death.
Garner E; Raj K
Cell Cycle; 2008 Feb; 7(3):277-82. PubMed ID: 18235223
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor p53: not a repressor, solely an activator.
Fischer M; Steiner L; Engeland K
Cell Cycle; 2014; 13(19):3037-58. PubMed ID: 25486564
[TBL] [Abstract][Full Text] [Related]
15. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.
Uxa S; Bernhart SH; Mages CFS; Fischer M; Kohler R; Hoffmann S; Stadler PF; Engeland K; Müller GA
Nucleic Acids Res; 2019 Sep; 47(17):9087-9103. PubMed ID: 31400114
[TBL] [Abstract][Full Text] [Related]
16. DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death.
Hill R; Madureira PA; Waisman DM; Lee PW
Oncotarget; 2011 Dec; 2(12):1094-108. PubMed ID: 22190353
[TBL] [Abstract][Full Text] [Related]
17. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
Hoffman WH; Biade S; Zilfou JT; Chen J; Murphy M
J Biol Chem; 2002 Feb; 277(5):3247-57. PubMed ID: 11714700
[TBL] [Abstract][Full Text] [Related]
19. Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest.
Levesque AA; Fanous AA; Poh A; Eastman A
Mol Cancer Ther; 2008 Feb; 7(2):252-62. PubMed ID: 18281511
[TBL] [Abstract][Full Text] [Related]
20. Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis.
Pratama E; Tian X; Lestari W; Iseki S; Ichwan SJ; Ikeda MA
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):248-54. PubMed ID: 26519881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
